CONTACTS 

SUBJECTS
Coagulapathy Report Submit to Kaiser Oncology Genetic Disposition Bl

1403 -
1403 -    ..
1404 - Summary/Objective
1405 -
140501 - Follow up ref SDS 17 0000. ref SDS 15 0000.
140502 -
140503 - Millie submitted the report to the doctor via letter and attachment
140504 - sent to Arlette at Kaiser.
140505 -
140506 -        [On 061110 primary care physician received the coagulapathy
140507 -        report on first-degree relative submitted today on 061103,
140508 -        ref SDS 19 VR6F; the paragraph on risks and follow up to
140509 -        treat pulmonary emboli, ref SDS 19 N18S, was highlighted in
140510 -        the doctor's printed version, ref SDS 20 N18S; the doctor
140511 -        advised that the report shows positive findings for
140512 -        acquired rather than inherited DNA genetic risk for blood
140513 -        clots, and in this case pulmonary emboli, ref SDS 20 626L;
140514 -        the doctor recommended against further measures to evaluate
140515 -        patient profile, including defer hypercoagulable state work
140516 -        up, and indicated no adjustments required in diagnosis and
140517 -        treatment. ref SDS 20 JT6N
140518 -
140519 -
140520 -
140521 -
140522 -
140524 -  ..
1406 -
1407 -
1408 - Progress
1409 -
140901 - Factor V and Prothrombin G20210A Mutations Negative
140902 - Coagulapathy Lab Family Member May Indicate Genetic Risk for PE
140903 - Lupus and Cardiolipin AB IGM Positive Genetic Risk Pulmonary Embolism
140904 -
140905 - Follow up ref SDS 17 VR6F.
140906 -
140907 - Millie submitted ref DIT 1 0001 for Arlette to forward to the doctor,
140908 - and transmitting the coagulapathy report using a PDF file...
140909 -
140910 -                      G:/08/02/04/60/06/11/0102A.PDF
140911 -
140912 - ...received with Ron's letter ref DRP 6 0001 yesterday, 061102,
140913 - ref SDS 17 VR6F, as discussed with the primary care physician on
140914 - 061020. ref SDS 11 ES3I   BCC was sent the family member.
140916 -         ..
140917 -    1.  Thanks for your kindness and support with communications at
140918 -        Kaiser.
140920 -  ..
140921 - Arlette has continued to be effective assisting Kaiser, as reported
140922 - previously on 061027. ref SDS 12 QC5K
140924 -  ..
140925 - Arlette's letter later that day, was received late at night after
140926 - Millie was admitted to the hospital.  Arlette reported distributing
140927 - notice to Kaiser of Millie's new problem, and facilitating advice from
140928 - Oncology. ref SDS 12 SG6H
140930 -  ..
140931 - Letter to Kaiser continues...
140932 -
140933 -        You probably know that my report to you of a rash on my lower
140934 -        arm with a few "light sprinkles of dots' in the morning, and
140935 -        which I thought really didn't need to bother the doctor about,
140936 -        ref SDS 12 MS3Q, turned into a big mess by the afternoon, and I
140937 -        was back in the ER, and then hospitalized. ref SDS 13 KZ9J  The
140938 -        doctor released me on Wednesday to come home. ref SDS 16 JR9N
140939 -        I seem to be stable for now.  Feels great to flex my "shopping"
140940 -        muscles.  Just wondering what will pop up next on the medical
140941 -        "radar." My big hope right now is to get well enough to fly.
140942 -        Doctor Johnson has grounded me for awhile.  I would love to see
140943 -        Greece, maybe Egypt, and Israel (with flack jacket of course).
140944 -        ref DIT 1 0001
140946 -  ..
140947 - This responds to Arlette's letter on 061027 asking Millie for results
140948 - of treatment in the Emergency Room. ref SDS 12 UP5F
140950 -  ..
140951 - Letter to Arlette continues...
140952 -
140953 -    2.  During my regular "treatment cycle" meeting with the doctor on
140954 -        October 20, he asked to see a coagulapathy report on my son,
140955 -        who was treated this past July for recurrent pulmonary
140956 -        embolism.  Since I am also being treated for recurrent PE, the
140957 -        genetic link requires investigation to assess my personal
140958 -        risks.  Yesterday, I received the report, which consists of 5
140959 -        pages in PDF file format, and apparently rendering documents
140960 -        faxed via telephone.  The quality is very poor and difficult to
140961 -        read.  To support review by the doctor, I summarize findings...
140962 -        ref DIT 1 PU6G
140964 -             ..
140965 -            [On 061110 primary care physician received the coagulapathy
140966 -            report on first-degree relative submitted today on 061103,
140967 -            ref SDS 20 VR6F; the paragraph on risks and follow up to
140968 -            treat pulmonary emboli, ref SDS 20 N18S, was highlighted in
140969 -            the doctor's printed version, ref SDS 20 N18S; the doctor
140970 -            advised that the report shows positive findings for
140971 -            acquired rather than inherited DNA genetic risk for blood
140972 -            clots, and in this case pulmonary emboli, ref SDS 20 626L;
140973 -            the doctor recommended against further measures to evaluate
140974 -            patient profile, including defer hypercoagulable state work
140975 -            up, and indicated no adjustments required in diagnosis and
140976 -            treatment. ref SDS 20 JT6N
140978 -         ..
140979 -    3.  Hypercoagulable state work up of family member who recently
140980 -        suffered recurrent pulmonary emboli indicates factor V and
140981 -        prothrombin G20210A mutations are negative.  Test results are,
140982 -        however, consistent with a Lupus Anticoagulant (an
140983 -        antiphospholipid antibody).  Cardiolipin AB IGM tested at 23,
140984 -        well above the target range of 15 that signals positive
140985 -        results.  The number "23" is circled in handwriting, indicating
140986 -        heightened interest.  There is no analysis nor summary
140987 -        explanation expressly stating genetic risk for thrombosis,
140988 -        including pulmonary emboli.  Prior research seems to suggest
140989 -        these findings demonstrate genetic disposition for PE in the
140990 -        family member. and further that patients with family history of
140991 -        blood clot problems together with recurrent thrombosis present
140992 -        as "strongly thrombophilic" and should get extensive evaluation
140993 -        for thrombophilias to guide diagnosis and treatment.
140994 -        ref DIT 1 N18S
140995 -
140996 -            [On 061110 primary care physician received the coagulapathy
140997 -            report on first-degree relative submitted today on 061103,
140998 -            ref SDS 0 VR6F; the paragraph on risks and follow up to
140999 -            treat pulmonary emboli, ref SDS 0 N18S, was highlighted in
141000 -            the doctor's printed version, ref SDS 20 N18S; the doctor
141001 -            advised that the report shows positive findings for
141002 -            acquired rather than inherited DNA genetic risk for blood
141003 -            clots, and in this case pulmonary emboli, ref SDS 20 626L;
141004 -            the doctor recommended against further measures to evaluate
141005 -            patient profile, including defer hypercoagulable state work
141006 -            up, and indicated no adjustments required in diagnosis and
141007 -            treatment. ref SDS 20 JT6N
141009 -         ..
141010 -    4.  Please pass this along to the doctor in time for discussion
141011 -        when we meet next Friday, November 10th. ref DIT 1 N19X
141013 -         ..
141014 -    5.  Thanks again for help last Friday, alerting the doctor to my ER
141015 -        situation. ref DIT 1 N14R
141016 -
141017 -
141018 -
141019 -
141020 -
141021 -
141022 -
141023 -
141024 -
1411 -